Results 181 to 190 of about 85,886 (213)

Complete loss of the atrial natriuretic peptide-converting enzyme Corin and CHAF-LA syndrome: Implications to natriuretic peptide physiology and left atrium health. [PDF]

Clin Transl Med
Kurolap A, Chai Gadot C, Zahler D, Ablin JN, Baris Feldman H.   +4 more
europepmc   +1 more source

New retinoblastoma (RB) drug delivery approaches: anti-tumor effect of atrial natriuretic peptide (ANP)-conjugated hyaluronic-acid-coated gold nanoparticles for intraocular treatment of chemoresistant RB. [PDF]

Mol Oncol
Haase A, Miroschnikov N, Klein S, Doege A, Dünker N, Van Meenen D, Junker A, Göpferich A, Apaolaza PS, Busch MA.   +9 more
europepmc   +1 more source

Atrial natriuretic peptide signaling co-regulates lipid metabolism and ventricular conduction system gene expression in the embryonic heart. [PDF]

iScience
Mishra A, Tavasoli M, Sokolenko S, McMaster CR, Pasumarthi KBS.   +4 more
europepmc   +1 more source

Deletion of AT_1a receptors selectively in the proximal tubules of the kidney alters the hypotensive and natriuretic response to atrial natriuretic peptide via NPR_A/cGMP/NO signaling.

Am J Physiol Renal Physiol
Li XC, Wang CH, Hassan R, Katsurada A, Sato R, Zhuo JL.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

HUMAN ATRIAL NATRIURETIC PEPTIDE

Clinical Endocrinology, 1987
Atrial peptides have been the subject of increasing attention since de Bold demonstrated that atrial extracts, when administered to anaethetized rats, induced a potent natriuretic and diuretic response (de Bold, 1979; de Bold et al., 198 1). Within 3 years, specific peptides with natriuretic and vasorelaxant activities were isolated, identified and ...
E A, Espiner, M G, Nicholls
openaire   +2 more sources

Atrial natriuretic peptide stability

Clinical Biochemistry, 2008
Atrial natriuretic peptide (ANP) is a key regulator in the homeostasis of water excretion and has emerged as an important prognostic marker for symptomatic chronic heart failure (CHF). The stability of ANP represents a crucial factor in assessing its use as a cardiac biomarker.
Ronald, Zolty, Carol, Bauer, Pamila, Allen, Maureen, Garrity, Timothy J, Vittorio   +4 more
openaire   +2 more sources

Atrial natriuretic peptide in man

American Journal of Nephrology, 1988
The heart is the major source of atrial natriuretic peptides (ANP). A propeptide is stored in atrial myocytes. In normal humans, atrial distension secondary to volume overload and/or increased atrial pressures are thought to stimulate the secretion of biologically active alpha-ANP (ANF-[99-126], 28 amino residues) into the circulation.
P, Weidmann, H, Saxenhofer, C, Ferrier, S G, Shaw   +3 more
openaire   +3 more sources

Atrial natriuretic peptide and related peptides

Clinical Chemical Laboratory Medicine, 2007
AbstractIn recent years, biomarkers have been recognized as important tools for diagnosis, risk stratification, and therapeutic decision-making in cardiovascular diseases. Currently, the clinical potential of several natriuretic peptides is under scientific investigation.
Akashi, Yoshihiro J., Springer, Jochen, Lainscak, Mitja, Anker, Stefan D.   +3 more
openaire   +3 more sources

Atrial Natriuretic Peptide

Nature Biotechnology, 1988
Atrial natriuretic peptide (ANP) stimulates vasodilation, fluid egress, increased glomerular filtration and salt and water excretion, and blocks the release and/or actions of several hormones, including angiotensin II, aldosterone and vasopressin. ANP levels are commonly elevated in situations of excessive fluid volume or hypertension, and the hormone ...
John D. Baxter, John A. Lewicki, David G. Gardner   +2 more
openaire   +3 more sources